A Comparison of Human Pulmonary Arterial and Venous Prostacyclin and Thromboxane Synthesis- Effect of a Thromboxane Synthase Inhibitor

Summary

The amounts of 6-keto-prostaglandin F_1α (6-keto-PGF_1α) and thromboxane B₂ (TxB₂) produced by the endothelial surfaces of paired samples of human pulmonary arteries and veins, obtained from patients undergoing thoracic surgery, were measured. The amounts of 6-keto-PGF_1α and TxB₂ produced by arteries compared with veins were not different. However, both arteries and veins produced more 6-keto-PGF_lα than TxB₂, the ratio being approximately 7.5:1 for both. 6-keto-PGF_lα synthesis by arteries was significantly correlated with that produced by veins but the relative amounts of TxB₂ were not correlated. 6-keto-PGF_lα synthesis was correlated with TxB₂ synthesis for veins but not for arteries. 8 of the 12 arterial samples exhibited some degree of intimal fibrosis.

Incubation with the thromboxane synthase inhibitor, dazoxiben, caused a significant inhibition of vascular TxB₂ synthesis and a significant increase in 6-keto-PGF_lα synthesis. In 3 of the 5 cases the increase in 6-keto-PGF_lα was too large to be explained by the fall in TxB₂.

Keywords

Pulmonary arteries - Pulmonary veins - 6-keto-prostaglan-din F_lα - Thromboxane B₂ - Thromboxane synthase inhibitor

• References

• 1 Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-2998
• 2 Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665
• 3 Tuvemo T, Strandberg K, Hamberg M, Samuelsson B. Formation and action of prostaglandin endoperoxides in the isolated human umbilical artery. Acta Physiol Scan 1976; 96: 145-149
• 4 Johnson AR. Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins J Clin Invest 1980; 65: 841-850
• 5 Metha P, Metha J, Crews F, Roy L, Ostrowski N, Horalek C. Comparison of umbilical vein models for measurement of relative prostacyclin and thromboxane production. Prostaglandins 1982; 24: 743-749
• 6 Semeri GG N, Abbate R, Gensini GF, Panetta A, Casolo GC, Carini M. TxA₂ production by human arterties and veins. Prostaglandins 1983; 25: 753-766
• 7 Mehta J, Roberts J. Human vascular tissues produce thromboxane as well as prostacyclin. Am J Physiol 1983; 244: R839-R844
• 8 Saldeen P, Saldeen T. 6-keto-F₁-/thromboxane B₂ratio in vascular and lung tissue. Thromb Res 1983; 30: 643-650
• 9 Ally AI, Horrobin DF. Thromboxane A₂ in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension. Prostaglandins Med 1980; 4: 431-438
• 10 Serneri GG N, Masoit G, Gensini G, Pogges IL, Abbati A, Manelli M. Prostacyclin and thromboxane A₂ formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation. Cardiovasc Res 1981; 15: 287-295
• 11 Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Eng J Med 1979; 300: 1142-1147
• 12 Poyser NL. Development and use of a radioimmunoassay for measuring 6-oxo-prostaglandin F_1α . Dev Pharmacol 1980; 1: 44-45
• 13 Cowley AJ, Jones EW, Hanley SP. Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction response to cold stimulation, and on human blood vessel prostacyclin production. Br J Clin Pharmacol 1983; 15: 107S-112S